What's the role of topiramate in the management of patients with hyperkinetic movement disorders?
| Autor: | Giovambattista De Sarro, Luca Gallelli, Antonio Siniscalchi, Chiara Giofrè |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Pharmacology
Topiramate Movement disorders Movement Disorders Essential tremor Chorea General Medicine Fructose Neurotransmission Hyperkinesis medicine.disease Epilepsy Glutamatergic Neuroprotective Agents medicine Animals Humans Restless legs syndrome medicine.symptom Nervous System Diseases Psychology Neuroscience medicine.drug |
| Zdroj: | Pharmacological reports : PR. 64(1) |
| ISSN: | 2299-5684 |
| Popis: | Topiramate (TPM) is an O-alkyl sulfamate derivative of the naturally occurring monosaccharide D-fructose with an epileptic activity. However, it has been suggested that, in addition to its use in epilepsy, TPM could also be used in the treatment of neurological disorders, psychiatric conditions and hyperkinetic movement disorders. The clinical applications of TPM in hyperkinetic movement disorders is consistent with the multiple pharmacodynamic mechanisms e.g., the modulation of both γ-aminobutyric acidergic or glutamatergic neurotransmission and the modulation of voltage-gated ion channels or intracellular signalling pathways. The purpose of the present review is to describe the mechanisms of action of TPM and its clinical efficacy in patients with hyperkinetic movement disorders. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink